Royal Oak Med

Executive Summary

Royal Oak Medical is a US-based medical device and drug delivery company founded in 2018, operating an ISO 13485:2016 certified manufacturing facility in Royal Oak, Michigan. The company specializes in precision-engineered implants, components, and FDA 510(k) approved devices, offering comprehensive in-house design, engineering, and manufacturing services using advanced materials and technologies. With a focus on quality and regulatory compliance, Royal Oak Medical serves as a contract manufacturer for medical device companies, leveraging its state-of-the-art facility to produce high-precision components. The company's strategy centers on expanding its device portfolio and manufacturing capabilities to capture growth in the orthopedic and drug delivery markets. While private and lacking disclosed financials, Royal Oak Medical's established ISO certification and FDA track record position it as a reliable partner in the medical device supply chain. Near-term growth is expected to be driven by new product introductions and capacity expansions, though competitive pressures and customer concentration risks remain.

Upcoming Catalysts (preview)

• Q3 2026New FDA 510(k) Clearance for Next-Generation Implant70% success
• Q4 2026Strategic Partnership with Major Orthopedic OEM50% success
• Q2 2026Expansion of Manufacturing Capacity80% success